Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281626 No. of Pages: 105 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in Global, including the following market information:
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Durvalumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Post-Polycythemia Vera Myelofibrosis (PPV-MF) include AbbVie Inc, Celgene Corp, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, Incyte Corp, Italfarmaco SpA, JW Pharmaceutical Corp and MedImmune LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Post-Polycythemia Vera Myelofibrosis (PPV-MF) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Segment Percentages, by Type, 2021 (%)
Durvalumab
Givinostat
Glasdegib
Idelalisib
IMG-7289
Others
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Celgene Corp
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
Incyte Corp
Italfarmaco SpA
JW Pharmaceutical Corp
MedImmune LLC
MEI Pharma Inc
Merck & Co Inc
Novartis AG
NS Pharma Inc
Promedior Inc
Sun Pharma Advanced Research Company Ltd
1 Introduction to Research & Analysis Reports
1.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Overall Market Size
2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size: 2021 VS 2028
2.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players in Global Market
3.2 Top Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies Ranked by Revenue
3.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Companies
3.4 Top 3 and Top 5 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players in Global Market
3.6.1 List of Global Tier 1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies
3.6.2 List of Global Tier 2 and Tier 3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Markets, 2021 & 2028
4.1.2 Durvalumab
4.1.3 Givinostat
4.1.4 Glasdegib
4.1.5 Idelalisib
4.1.6 IMG-7289
4.1.7 Others
4.2 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue & Forecasts
4.2.1 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2022
4.2.2 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2023-2028
4.2.3 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue & Forecasts
5.2.1 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2022
5.2.2 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2023-2028
5.2.3 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2021 & 2028
6.2 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue & Forecasts
6.2.1 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2022
6.2.2 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2023-2028
6.2.3 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2028
6.3.2 US Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.3.3 Canada Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.3.4 Mexico Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2028
6.4.2 Germany Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4.3 France Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4.4 U.K. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4.5 Italy Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4.6 Russia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4.7 Nordic Countries Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.4.8 Benelux Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2028
6.5.2 China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.5.3 Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.5.4 South Korea Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.5.5 Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.5.6 India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2028
6.6.2 Brazil Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.6.3 Argentina Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2017-2028
6.7.2 Turkey Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.7.3 Israel Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.7.4 Saudi Arabia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
6.7.5 UAE Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.1.4 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.1.5 AbbVie Inc Key News
7.2 Celgene Corp
7.2.1 Celgene Corp Corporate Summary
7.2.2 Celgene Corp Business Overview
7.2.3 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.2.4 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.2.5 Celgene Corp Key News
7.3 CTI BioPharma Corp
7.3.1 CTI BioPharma Corp Corporate Summary
7.3.2 CTI BioPharma Corp Business Overview
7.3.3 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.3.4 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.3.5 CTI BioPharma Corp Key News
7.4 F. Hoffmann-La Roche Ltd
7.4.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.4.2 F. Hoffmann-La Roche Ltd Business Overview
7.4.3 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.4.5 F. Hoffmann-La Roche Ltd Key News
7.5 Gilead Sciences Inc
7.5.1 Gilead Sciences Inc Corporate Summary
7.5.2 Gilead Sciences Inc Business Overview
7.5.3 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.5.4 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.5.5 Gilead Sciences Inc Key News
7.6 Incyte Corp
7.6.1 Incyte Corp Corporate Summary
7.6.2 Incyte Corp Business Overview
7.6.3 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.6.4 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.6.5 Incyte Corp Key News
7.7 Italfarmaco SpA
7.7.1 Italfarmaco SpA Corporate Summary
7.7.2 Italfarmaco SpA Business Overview
7.7.3 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.7.4 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.7.5 Italfarmaco SpA Key News
7.8 JW Pharmaceutical Corp
7.8.1 JW Pharmaceutical Corp Corporate Summary
7.8.2 JW Pharmaceutical Corp Business Overview
7.8.3 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.8.4 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.8.5 JW Pharmaceutical Corp Key News
7.9 MedImmune LLC
7.9.1 MedImmune LLC Corporate Summary
7.9.2 MedImmune LLC Business Overview
7.9.3 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.9.4 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.9.5 MedImmune LLC Key News
7.10 MEI Pharma Inc
7.10.1 MEI Pharma Inc Corporate Summary
7.10.2 MEI Pharma Inc Business Overview
7.10.3 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.10.4 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.10.5 MEI Pharma Inc Key News
7.11 Merck & Co Inc
7.11.1 Merck & Co Inc Corporate Summary
7.11.2 Merck & Co Inc Business Overview
7.11.3 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.11.4 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.11.5 Merck & Co Inc Key News
7.12 Novartis AG
7.12.1 Novartis AG Corporate Summary
7.12.2 Novartis AG Business Overview
7.12.3 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.12.4 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.12.5 Novartis AG Key News
7.13 NS Pharma Inc
7.13.1 NS Pharma Inc Corporate Summary
7.13.2 NS Pharma Inc Business Overview
7.13.3 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.13.4 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.13.5 NS Pharma Inc Key News
7.14 Promedior Inc
7.14.1 Promedior Inc Corporate Summary
7.14.2 Promedior Inc Business Overview
7.14.3 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.14.4 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.14.5 Promedior Inc Key News
7.15 Sun Pharma Advanced Research Company Ltd
7.15.1 Sun Pharma Advanced Research Company Ltd Corporate Summary
7.15.2 Sun Pharma Advanced Research Company Ltd Business Overview
7.15.3 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.15.4 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2017-2022)
7.15.5 Sun Pharma Advanced Research Company Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com